Identification of a promoter in position 56 within the long control region of human papillomavirus type 18

Archives of Virology

Volumn 146, Issue 11, 2001, Pages 2069-2084

  Steger, G ^a   Rehtanz, M ^a   Schnabel, C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINE; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PROMOTER REGIONS (GENETICS); TATA BOX; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18;

EID: 0035208333     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050170021     Document Type: Article

References (47)

1. Overexpression of C/EBPb represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein
2. The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3t3 and Rat-1 cells
3. Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in non tumorigenic HeLa X fibroblast hybrid cells
4. Prevalence of human papillomaviruses in cervical cancer: A worldwide perspective
5. An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV18 transcription
6. Transcriptional control of human papillomavirus (HPV) oncogene expression: Composition of the HPV type 18 upstream regulatory region
7. Two AP1 sites in the long control region of human papillomavirus type 16 lead to phorbolester stimulation of the viral E6/E7 promoter
8. The nucleotide sequence and genome organization of human papillomavirus Type 18
9. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules
10. The E2 transcriptional repressor can compensate for SP1 activation of the human papillomavirus type 18 early promoter
11. Different mechanisms contribute to the E2-mediated transcriptional control of human papillomavirus type 18 viral oncogenes
12. Expression of papillomavirus E2 protein in HeLa cells leads to apoptosis
13. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers
14. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates
15. Sequences homologous to 5′splice sites are required for the inhibitory activity of papillomavirus late 3′ untranslated regions
16. Ribonuclease protection assay
17. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence aberrant Sp1 distal element
18. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure
19. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1
20. Role of E6 and E7 oncoproteins in HPV-induced anogenital malignancies
21. Human papillomavirus infection of the cervix: Relative risk association of 15 common anogenital types
22. Tissue culture techniques for the study of human papillomaviruses in stratified epithelia
23. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation
24. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b
25. Malignant transformation of cutaneous lesions in renal allograft patients: A role of human papillomaviruses
26. Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16
27. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters
28. Point mutations in SP1 motifs in the upstream regulatory region of HPV18 isolates from cervical cancers increase promoter activity
29. Sequence variation in the upstream regulatory region of HPV18 isolates from cervical cancers
30. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes
31. Integration of human papillomavirus type 16 DNA sequences: A possible early event in the progression of genital tumors
32. Cis-acting negative RNA elements on papillomavirus late m-RNAs
33. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
34. Transcription of human papillomavirus type 16 early genes in cervical cancers and a cancer derived cell line and identification of the E7 protein
35. mRNA instability elements in the human papillomavirus type 16 coding region
36. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein
37. Differentiation-linked human papillomavirus type 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA robes
38. Efficient expression of human papillomavirus type 16 L1 protein in epithelial cells by using rev and the rev-responsive element of human immunodeficiency virus or cis-acting transactivation elements of simian retroviruses type1
39. Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens
40. Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes
41. Modulation of firefly luciferase stability and impact studies of gene regulation
42. The structure, function, and regulation of papillomaviral genes in infection and cervical cancer
43. Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro
44. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis